1月14日 - ** 医疗设备制造商直觉外科ISRG.O股价下跌5.7%至529.85美元
** ISRG预计2026年全球达芬奇手术量将同比增长13%至15%
** 摩根大通（JPMorgan）表示，公司前景 "比我们预期的+13%至16%略低"。
** Truist称 "预期手术量至少增长1%，但实际持平仍略低于该预期"。
** 根据 LSEG 的数据，ISRG 预计第四季度营收约为 28.7 亿美元，而分析师预计为 27.2 亿美元。
** 该公司预计 2025 财年营收约为 100.6 亿美元，而预期为 99.2 亿美元。
** 截至上次收盘，ISRG在过去12个月中上涨了4.3%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.